| Primary |
| Hypertension |
75.3% |
| Product Used For Unknown Indication |
4.5% |
| Arthralgia |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Essential Hypertension |
1.9% |
| Hyperuricaemia |
1.9% |
| Pain |
1.9% |
| Blood Pressure Increased |
1.3% |
| Infection |
1.3% |
| Renal Failure Chronic |
1.3% |
| Anaemia |
0.6% |
| Arthritis |
0.6% |
| Atrial Fibrillation |
0.6% |
| Blood Pressure |
0.6% |
| Cardiac Disorder |
0.6% |
| Cardiac Failure |
0.6% |
| Coronary Artery Disease |
0.6% |
| Diabetes Mellitus Non-insulin-dependent |
0.6% |
| Hepatic Cirrhosis |
0.6% |
| Hypovitaminosis |
0.6% |
|
| Angioedema |
18.8% |
| Hyperkalaemia |
11.9% |
| Wheezing |
11.9% |
| Renal Failure Acute |
7.9% |
| Completed Suicide |
6.9% |
| Swollen Tongue |
6.9% |
| Angioneurotic Oedema |
5.0% |
| Dyspnoea |
4.0% |
| Cough |
3.0% |
| Drug Ineffective |
3.0% |
| Vomiting |
3.0% |
| Gastrostomy Tube Insertion |
2.0% |
| Glossitis |
2.0% |
| Hypoaesthesia |
2.0% |
| Interstitial Lung Disease |
2.0% |
| Nausea |
2.0% |
| Oedema Peripheral |
2.0% |
| Pruritus |
2.0% |
| Renal Failure |
2.0% |
| Renal Impairment |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.1% |
| Hypertension |
19.4% |
| Type 2 Diabetes Mellitus |
10.4% |
| Product Used For Unknown Indication |
6.3% |
| Unevaluable Event |
4.4% |
| Prophylaxis |
3.1% |
| Chemotherapy |
2.9% |
| Helicobacter Infection |
1.9% |
| Prophylaxis Of Nausea And Vomiting |
1.9% |
| Cardiac Failure |
1.7% |
| Diabetes Mellitus |
1.7% |
| Blood Pressure Increased |
1.5% |
| Drug Exposure During Pregnancy |
1.5% |
| Accidental Exposure |
1.2% |
| Appetite Disorder |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Hypertensive Heart Disease |
1.2% |
| Nausea |
1.2% |
| Wound Infection |
1.2% |
| Cardiac Failure Congestive |
1.0% |
|
| Completed Suicide |
17.1% |
| Vomiting |
10.5% |
| Syncope |
9.2% |
| Renal Failure Acute |
7.9% |
| White Blood Cell Count Decreased |
6.6% |
| Ventricular Extrasystoles |
5.3% |
| Antipsychotic Drug Level Below Therapeutic |
3.9% |
| Drug Hypersensitivity |
3.9% |
| Drug Toxicity |
3.9% |
| Hyperkalaemia |
3.9% |
| Poisoning |
3.9% |
| Anaemia |
2.6% |
| Cough |
2.6% |
| Dizziness |
2.6% |
| Drug Ineffective |
2.6% |
| Gastrointestinal Haemorrhage |
2.6% |
| Hepatorenal Syndrome |
2.6% |
| Hyponatraemia |
2.6% |
| Lactic Acidosis |
2.6% |
| Pulmonary Oedema |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.4% |
| Hypertension |
16.1% |
| Product Used For Unknown Indication |
15.5% |
| Diabetes Mellitus |
6.2% |
| Type 2 Diabetes Mellitus |
3.3% |
| Blood Pressure |
2.7% |
| Osteoporosis |
2.6% |
| Blood Cholesterol Increased |
2.6% |
| Cardiac Failure |
2.5% |
| Pain |
2.5% |
| Multiple Myeloma |
2.5% |
| Depression |
2.2% |
| Atrial Fibrillation |
2.0% |
| Rheumatoid Arthritis |
1.8% |
| Prophylaxis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Cardiac Disorder |
1.5% |
| Arthritis |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Anxiety |
1.3% |
|
| Vomiting |
12.6% |
| Weight Decreased |
10.0% |
| Myocardial Infarction |
9.7% |
| Weight Increased |
6.2% |
| Thrombocytopenia |
5.6% |
| Hypotension |
4.7% |
| Pulmonary Embolism |
4.4% |
| Renal Failure |
4.1% |
| Renal Failure Acute |
4.1% |
| Tremor |
4.1% |
| Unevaluable Event |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Cerebrovascular Accident |
3.5% |
| Dyspnoea |
3.5% |
| Syncope |
3.5% |
| Blood Glucose Increased |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Pain In Extremity |
3.2% |
| Pruritus |
3.2% |
| Therapeutic Agent Toxicity |
3.2% |
|
